TAIMED BIOLOGICS INC.
Area: CDMO
Booth No: M104
Website: http://www.taimedbiologics.com/
Exhibitor Profile
TaiMed Biologics was formed in 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy unmet medical needs. We have vast experience in mAb development and manufacturing and successfully launched the first and only mAb for HIV treatment in US and EU (Trogarzo®).
With our massive expertise, we provide CDMO services including GMP manufacturing, process/ analytical method development, and validation to propel client's commercialization process.
Video
Exhibit Products
-
Trogarzo (Ibalizumab)
-
Antibody-Drug Conjugates, ADCs
-
TMB-365/TMB-380 (TMB-365 and TMB-380 combination)
-
Regulatory Affairs
-
Process Development
-
Formulation Development
-
cGMP Manufacturing
-
TMB-365
-
Analysis and Analytical Method Development
Exhibitor Press Release
- Join TaiMed Biologics and Lourdes for Inspiring Activities at BioAsia 2024 2024-07-17
- TaiMed Biologics Showcases Innovative HIV Therapies at BioAsia 2024 2024-07-10
- TaiMed Biologics: Comprehensive CDMO Services from Bench to Market 2024-06-25
Exhibitors you may be interested in
Highest Rated